vanillylmandelic acid melanotic neuroectodermal tumor of infancy infancy: Review of literature, report of a case and follow up at 7 years Melanotic Neuroectodermal Tumor of Infancy:
Description
The trial concluded that AOD-9604 did not induce significant weight loss, leading to a halt in the development of the drug as a weight-loss solution

This product is not a substitute for a varied and balanced diet and a healthy lifestyle

Inhibiting the TCA cycle or OXPHOS can alleviate this process (38)

USA 98 , 78637868, (2001)